186 related articles for article (PubMed ID: 32967112)
21. Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors.
Martínez-Fernández P; Pose P; Dolz-Gaitón R; García A; Trigo-Sánchez I; Rodríguez-Zarco E; Garcia-Ruiz M; Barba I; Izquierdo-García M; Valero-Garcia J; Ruiz C; Lázaro M; Carbonell P; Gargallo P; Méndez C; Ríos-Martín JJ; Palmeiro-Uriach A; Camarasa-Lillo N; Forteza-Vila J; Calabria I
J Pers Med; 2021 Apr; 11(5):. PubMed ID: 33947144
[TBL] [Abstract][Full Text] [Related]
22. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of next generation sequencing based 35-gene hereditary cancer panel.
Chan W; Lee M; Yeo ZX; Ying D; Grimaldi KA; Pickering C; Yang MMS; Sundaram SK; Tzang LCH
Hered Cancer Clin Pract; 2020; 18():9. PubMed ID: 32368312
[TBL] [Abstract][Full Text] [Related]
24. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
[TBL] [Abstract][Full Text] [Related]
25. Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification.
Thakral D; Kaur G; Gupta R; Benard-Slagter A; Savola S; Kumar I; Anand R; Rani L; Verma P; Joshi S; Kumar L; Sharma A; Bakhshi S; Seth R; Singh V
Front Oncol; 2019; 9():871. PubMed ID: 31572674
[TBL] [Abstract][Full Text] [Related]
26. Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia.
Vega-Garcia N; Benito R; Esperanza-Cebollada E; Llop M; Robledo C; Vicente-Garcés C; Alonso J; Barragán E; Fernández G; Hernández-Sánchez JM; Martín-Izquierdo M; Maynou J; Minguela A; Montaño A; Ortega M; Torrebadell M; Cervera J; Sánchez J; Jiménez-Velasco A; Riesco S; Hernández-Rivas JM; Lassaletta Á; Fernández JM; Rives S; Dapena JL; Ramírez M; Camós M; On Behalf Of The Group Of Leukemia Of The Spanish Society Of Pediatric Hematology And Oncology Sehop
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33255984
[TBL] [Abstract][Full Text] [Related]
27. Rapid detection of copy number variations and point mutations in
Germani A; Libi F; Maggi S; Stanzani G; Lombardi A; Pellegrini P; Mattei M; De Marchis L; Amanti C; Pizzuti A; Torrisi MR; Piane M
Oncotarget; 2018 Sep; 9(72):33648-33655. PubMed ID: 30263092
[TBL] [Abstract][Full Text] [Related]
28. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Rosa-Rosa JM; Cuenca I; Medina A; Vázquez I; Sánchez-delaCruz A; Buenache N; Sánchez R; Jiménez C; Rosiñol L; Gutiérrez NC; Ruiz-Heredia Y; Barrio S; Oriol A; Martin-Ramos ML; Blanchard MJ; Ayala R; Ríos-Tamayo R; Sureda A; Hernández MT; de la Rubia J; Alkorta-Aranburu G; Agirre X; Bladé J; Mateos MV; Lahuerta JJ; San-Miguel JF; Calasanz MJ; Garcia-Sanz R; Martínez-Lopez J
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291952
[TBL] [Abstract][Full Text] [Related]
29. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
Aguilera-Diaz A; Vazquez I; Ariceta B; Mañú A; Blasco-Iturri Z; Palomino-Echeverría S; Larrayoz MJ; García-Sanz R; Prieto-Conde MI; Del Carmen Chillón M; Alfonso-Pierola A; Prosper F; Fernandez-Mercado M; Calasanz MJ
PLoS One; 2020; 15(1):e0227986. PubMed ID: 31978184
[TBL] [Abstract][Full Text] [Related]
31. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms.
Carbonell D; Suárez-González J; Chicano M; Andrés-Zayas C; Triviño JC; Rodríguez-Macías G; Bastos-Oreiro M; Font P; Ballesteros M; Muñiz P; Balsalobre P; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540291
[TBL] [Abstract][Full Text] [Related]
33. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
[TBL] [Abstract][Full Text] [Related]
34. The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing.
Mahamdallie S; Ruark E; Holt E; Poyastro-Pearson E; Renwick A; Strydom A; Seal S; Rahman N
Wellcome Open Res; 2018; 3():68. PubMed ID: 30175241
[TBL] [Abstract][Full Text] [Related]
35. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
36. High-throughput detection of clinically targetable alterations using next-generation sequencing.
Vendrell JA; Grand D; Rouquette I; Costes V; Icher S; Selves J; Larrieux M; Barbe A; Brousset P; Solassol J
Oncotarget; 2017 Jun; 8(25):40345-40358. PubMed ID: 28404952
[TBL] [Abstract][Full Text] [Related]
37. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
[TBL] [Abstract][Full Text] [Related]
38. A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma.
Shao D; Lin Y; Liu J; Wan L; Liu Z; Cheng S; Fei L; Deng R; Wang J; Chen X; Liu L; Gu X; Liang W; He P; Wang J; Ye M; He J
Sci Rep; 2016 Mar; 6():22338. PubMed ID: 26936516
[TBL] [Abstract][Full Text] [Related]
39. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia.
Yoo JW; Ahn A; Lee JM; Jo S; Kim S; Lee JW; Cho B; Kim Y; Kim M; Chung NG
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]